D. E. Shaw & Co., Inc. Becton Dickinson & CO Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 598,422 shares of BDX stock, worth $133 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

598,422

Holding current value

$133 Million

% of portfolio

0.13%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$221.47 - $242.41 $22.1 Million - $24.2 Million	99,860 Added 20.03%	598,422 $144 Million
Q2 2024 Aug 14, 2024	BUY	$225.07 - $246.17 $6.7 Million - $7.33 Million	29,769 Added 6.35%	498,562 $117 Million
Q1 2024 May 15, 2024	BUY	$233.45 - $247.73 $4.31 Million - $4.57 Million	18,467 Added 4.1%	468,793 $116 Million
Q4 2023 Feb 14, 2024	BUY	$232.24 - $267.23 $42.4 Million - $48.8 Million	182,639 Added 68.23%	450,326 $110 Million
Q3 2023 Nov 14, 2023	SELL	$254.9 - $283.59 $4.78 Million - $5.32 Million	-18,766 Reduced 6.55%	267,687 $69.2 Million
Q2 2023 Aug 14, 2023	SELL	$238.39 - $265.32 $42.6 Million - $47.4 Million	-178,640 Reduced 38.41%	286,453 $75.6 Million
Q1 2023 May 15, 2023	BUY	$229.71 - $259.35 $10.2 Million - $11.5 Million	44,480 Added 10.58%	465,093 $115 Million
Q4 2022 Feb 14, 2023	BUY	$218.29 - $256.91 $23.6 Million - $27.8 Million	108,042 Added 34.57%	420,613 $107 Million
Q3 2022 Nov 14, 2022	SELL	$51.03 - $264.23 $1.99 Million - $10.3 Million	-39,083 Reduced 11.11%	312,571 $69.7 Million
Q2 2022 Aug 15, 2022	BUY	$234.74 - $275.42 $19.4 Million - $22.8 Million	82,703 Added 30.75%	351,654 $86.7 Million
Q1 2022 May 16, 2022	BUY	$243.64 - $270.48 $18 Million - $20 Million	74,024 Added 37.98%	268,951 $71.5 Million
Q4 2021 Feb 14, 2022	BUY	$230.08 - $250.94 $1.54 Million - $1.68 Million	6,699 Added 3.56%	194,927 $49 Million
Q3 2021 Nov 15, 2021	SELL	$232.72 - $256.47 $6.33 Million - $6.98 Million	-27,197 Reduced 12.62%	188,228 $46.3 Million
Q2 2021 Aug 16, 2021	SELL	$232.65 - $254.58 $17.4 Million - $19.1 Million	-74,965 Reduced 25.82%	215,425 $52.4 Million
Q1 2021 May 17, 2021	SELL	$232.09 - $256.88 $59.8 Million - $66.2 Million	-257,697 Reduced 47.02%	290,390 $70.6 Million
Q4 2020 Feb 16, 2021	SELL	$221.92 - $245.94 $12.9 Million - $14.3 Million	-57,985 Reduced 9.57%	548,087 $137 Million
Q3 2020 Nov 16, 2020	BUY	$215.77 - $276.76 $76.5 Million - $98.2 Million	354,762 Added 141.17%	606,072 $141 Million
Q2 2020 Aug 14, 2020	BUY	$219.9 - $263.41 $54 Million - $64.7 Million	245,610 Added 4308.95%	251,310 $60.1 Million
Q1 2020 May 15, 2020	SELL	$195.69 - $279.01 $1.44 Million - $2.05 Million	-7,351 Reduced 56.33%	5,700 $1.31 Million
Q4 2019 Feb 14, 2020	SELL	$236.45 - $266.82 $7.45 Million - $8.41 Million	-31,510 Reduced 70.71%	13,051 $3.55 Million
Q3 2019 Nov 14, 2019	SELL	$230.58 - $256.08 $17.9 Million - $19.8 Million	-77,500 Reduced 63.49%	44,561 $11.3 Million
Q2 2019 Aug 14, 2019	BUY	$217.4 - $246.08 $25.3 Million - $28.7 Million	116,546 Added 2113.25%	122,061 $30.8 Million
Q1 2019 May 15, 2019	SELL	$206.05 - $248.17 $6.95 Million - $8.37 Million	-33,725 Reduced 85.95%	5,515 $1.38 Million
Q4 2018 Feb 14, 2019	BUY	$204.73 - $257.93 $7.83 Million - $9.86 Million	38,240 Added 3824.0%	39,240 $8.84 Million
Q3 2018 Nov 14, 2018	SELL	$233.07 - $256.0 $6.51 Million - $7.15 Million	-27,943 Reduced 96.54%	1,000 $261,000
Q1 2018 May 15, 2018	SELL	$205.46 - $240.27 $8.34 Million - $9.75 Million	-40,590 Reduced 58.38%	28,943 $6.27 Million
Q4 2017 Feb 14, 2018	BUY	$189.0 - $222.64 $13.1 Million - $15.5 Million	69,533	69,533 $14.9 Million

Others Institutions Holding BDX

# of Institutions

1,737

Shares Held

250M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.4B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account